The overall goal of this project is to determine whether a new thiol compound (Rimatil) would be more effective and safer than Thiola in controlling cystinuria and cystine stone formations, and to ascertain if a new diphosphonate (alendronate) might prevent stone formation from prolonged immobilization. A dose response relation will be characterized in order to show that Rimatil is more effective than Thiola in lowering cystine excretion. A 3 yr. randomized trial between Rimatil and Thiola will be conducted in cystinuric patients, with the dose of each adjusted to achieve an optimum control of cystine excretion (250-400 mg/day). Endpoints will be drug dosage and side effect profile, with the expectation that Rimatil group would require a lower dose and improved safety of usage. Using bedrest model, stone formation during prolonged immobilization (or space flight) has been shown to be due to increased renal excretion of calcium and phosphate from bone loss. Alendronate might prevent the rise in urinary calcium and phosphate (and in urinary saturation of stone-forming calcium salts) by inhibiting bone resorption. This scheme will be tested in normal subjects undergoing 3 weeks of bedrest at Dallas and those participating in a 17-week bedrest study at Houston. These studies have biomedical importance, since they may allow improved treatment of cystinuria, and lead to the development of an effective countermeasure for stone-formation during space travel and other immobilization states.

Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Xu, Li Hao Richie; Maalouf, Naim M (2017) Effect of acute hyperinsulinemia on magnesium homeostasis in humans. Diabetes Metab Res Rev 33:
Xu, Li Hao Richie; Adams-Huet, Beverley; Poindexter, John R et al. (2017) Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation. J Urol 197:1465-1471
Sakhaee, Khashayar; Poindexter, John; Aguirre, Crystal (2016) The effects of bariatric surgery on bone and nephrolithiasis. Bone 84:1-8
Hu, Ming Chang; Shi, Mingjun; Cho, Han Jun et al. (2015) Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26:1290-302
Hajibeigi, Asghar; Dioum, Elhadji M; Guo, Jianfei et al. (2015) Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter in response to serum deprivation. Biochem Biophys Res Commun 465:414-420
Yoon, Vivienne; Adams-Huet, Beverley; Sakhaee, Khashayar et al. (2013) Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 98:2589-94
Capolongo, Giovanna; Abul-Ezz, Sameh; Moe, Orson W et al. (2012) Subclinical celiac disease and crystal-induced kidney disease following kidney transplant. Am J Kidney Dis 60:662-7
Cameron, MaryAnn; Maalouf, Naim M; Poindexter, John et al. (2012) The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney Int 81:1123-30
Sakhaee, Khashayar; Capolongo, Giovanna; Maalouf, Naim M et al. (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant 27:3201-9
Nguyen, Trang Q; Maalouf, Naim M; Sakhaee, Khashayar et al. (2011) Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol 6:1533-9

Showing the most recent 10 out of 226 publications